Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Aviceda Therapeutics, Inc.

0001824762-25-000001 · filed Jan 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$207,499,882
Reported amount sold
$74,999,940
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Aviceda Therapeutics, Inc.
CIK
1824762
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
ONE BROADWAY, 14TH FLOOR
CAMBRIDGE, Massachusetts 02142
Phone
617-332-0741

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗